EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,149,524 | -16.0% | 643,597 | +3.5% | 0.00% | – |
Q2 2023 | $12,085,576 | -43.7% | 621,686 | -17.8% | 0.00% | -100.0% |
Q1 2023 | $21,468,487 | -3.8% | 756,732 | -0.9% | 0.00% | 0.0% |
Q4 2022 | $22,326,079 | +9.0% | 763,807 | -1.5% | 0.00% | 0.0% |
Q3 2022 | $20,488,000 | -40.2% | 775,515 | +0.5% | 0.00% | 0.0% |
Q2 2022 | $34,288,000 | -11.3% | 771,759 | -1.2% | 0.00% | 0.0% |
Q1 2022 | $38,644,000 | -0.2% | 780,851 | +2.7% | 0.00% | 0.0% |
Q4 2021 | $38,724,000 | -9.0% | 760,468 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $42,564,000 | +32.0% | 763,066 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $32,240,000 | -0.1% | 753,280 | -2.6% | 0.00% | 0.0% |
Q1 2021 | $32,267,000 | -9.4% | 773,067 | +1.1% | 0.00% | 0.0% |
Q4 2020 | $35,622,000 | +13.5% | 764,935 | +3.5% | 0.00% | 0.0% |
Q3 2020 | $31,389,000 | -10.7% | 738,909 | +0.8% | 0.00% | 0.0% |
Q2 2020 | $35,167,000 | +3.3% | 732,944 | -0.9% | 0.00% | 0.0% |
Q1 2020 | $34,032,000 | -25.5% | 739,802 | -2.7% | 0.00% | -50.0% |
Q4 2019 | $45,683,000 | +6.2% | 760,370 | +0.0% | 0.00% | 0.0% |
Q3 2019 | $42,999,000 | +2.5% | 760,103 | +0.9% | 0.00% | 0.0% |
Q2 2019 | $41,952,000 | +10.0% | 753,474 | -0.3% | 0.00% | +100.0% |
Q1 2019 | $38,150,000 | +30.0% | 755,573 | +3.7% | 0.00% | 0.0% |
Q4 2018 | $29,348,000 | -37.3% | 728,409 | +7.9% | 0.00% | -50.0% |
Q3 2018 | $46,794,000 | +0.5% | 674,951 | +9.7% | 0.00% | 0.0% |
Q2 2018 | $46,567,000 | +52.6% | 615,477 | +6.2% | 0.00% | +100.0% |
Q1 2018 | $30,521,000 | +0.3% | 579,280 | +1.7% | 0.00% | 0.0% |
Q4 2017 | $30,438,000 | -9.8% | 569,794 | +0.7% | 0.00% | -50.0% |
Q3 2017 | $33,755,000 | -23.8% | 565,975 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $44,322,000 | +16.7% | 561,820 | +22.7% | 0.00% | 0.0% |
Q1 2017 | $37,991,000 | +11.7% | 458,060 | +6.8% | 0.00% | 0.0% |
Q4 2016 | $34,015,000 | +15.5% | 428,721 | +1.9% | 0.00% | 0.0% |
Q3 2016 | $29,446,000 | +109.3% | 420,661 | +16.0% | 0.00% | +100.0% |
Q2 2016 | $14,066,000 | -1.2% | 362,609 | +3.1% | 0.00% | 0.0% |
Q1 2016 | $14,242,000 | -55.2% | 351,676 | -2.0% | 0.00% | -50.0% |
Q4 2015 | $31,803,000 | -89.8% | 358,673 | -95.3% | 0.00% | -83.3% |
Q3 2015 | $311,540,000 | +1121.6% | 7,711,488 | +2345.0% | 0.01% | +500.0% |
Q2 2015 | $25,503,000 | +200.7% | 315,397 | +55.8% | 0.00% | +100.0% |
Q1 2015 | $8,481,000 | +1464.8% | 202,455 | +479.4% | 0.00% | – |
Q4 2014 | $542,000 | +29.0% | 34,942 | +5.1% | 0.00% | – |
Q3 2014 | $420,000 | +138.6% | 33,232 | +171.2% | 0.00% | – |
Q2 2014 | $176,000 | – | 12,252 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |